Observational Study in Preterm Infants With Intracranial Hemorrhage
NCT ID: NCT01620203
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2012-06-30
2023-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators showed that preterm infants with severe ICH have decreased cerebral oxygenation several weeks after the hemorrhage. The mechanisms involved in this state of decreased cerebral oxygenation in preterm infants and the effects on cerebral function are unknown.
This longitudinal observation study will evaluate physiologic parameters to determine trends in cerebral oxygenation and function in preterm infants with ICH in comparison to infants without ICH.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage
NCT03019692
Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)
NCT00817310
The Long-term Neurodevelopmental Outcome After Intraventricular Hemorrhage (IVH)-Grades I-II in Preterm Infants at Ages 1-7 Years
NCT01912703
Impact of Early and Severe Fetal Growth Restriction on Neurodevelopmental Outcomes in Preterm Infants
NCT05381272
Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome
NCT00957840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Matched group of control infants without diagnosis of intracranial hemorrhage
No intervention/treatment is given
Intracranial Hemorrhage
Group of preterm infant with diagnosis of intracranial hemorrhage.
No intervention/treatment is given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention/treatment is given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with ICH grades II or higher during the first week after birth
* Matched control infants without ICH.
Exclusion Criteria
* Birth asphyxia
* Not expected to survive
1 Day
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nelson Claure
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nelson Claure
Research Associate Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nelson Claure, M.Sc.,Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Eduardo Bancalari, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Deepak Jain, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Sethuraman Swaminathan, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Holtz Children's Hospital, Jackson Memorial Hospital/University of Miami Medical Center
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20120065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.